Active

Roche Venture Fund

Investor type

CVC

Founded

1896

AUM

$850 M

Location

Basel, Basel-Stadt, Switzerland

Investment Ticket

$5-10 m

Investment Stage

Seed Series B

Region of investment

Europe

ESG Focus

Impact investor
Investor profile last updated: 11 May, 2025

Profile

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).

Industry

Food and Beverage Foodtech Healthcare Services Software Life Sciences HealthTech Biotechnology Pharmaceuticals MedTech Medical Devices

Roche Venture Fund Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Roche Venture Fund
Corporate VC (CVC)
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
MedTech
Life Sciences
Seed
Series A
Series B
North America
$5-10 m
$516 M
December 2002

Contacts

Name
Title
Email
avatar
Heather Yoder Director Human Resources
Director Human Resources
h•••@•••
avatar
Ke Tang Principal Scientist Bioinformatics
Principal Scientist Bioinformatics
t•••@•••
Upgrade to see contacts
avatar
RzDX1EcSkPHIVe0p RzDX1EcSkPHIVe0p
RzDX1EcSkPHIVe0p
avatar
RzDX1EcSkPHIVe0p RzDX1EcSkPHIVe0p
RzDX1EcSkPHIVe0p
avatar
RzDX1EcSkPHIVe0p RzDX1EcSkPHIVe0p
RzDX1EcSkPHIVe0p
Investment-team contacts for Roche Venture Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Roche Venture Fund

Roche Venture Fund operates as a corporate VC (CVC). It backs companies at Seed and Series B, writing tickets of $5-10 m.
Roche Venture Fund is located in Basel, Basel-Stadt, Switzerland.
Roche Venture Fund was founded in 1896.
Roche Venture Fund invests in companies and startups in Food and Beverage, Foodtech, Healthcare Services, Software, Life Sciences, HealthTech, Biotechnology, Pharmaceuticals, MedTech, Medical Devices.
Roche Venture Fund invests in companies and startups in Europe.
Roche Venture Fund invests in companies and startups at Seed, Series B.
Roche Venture Fund usually invests $5-10 m on average.
Roche Venture Fund has around $850m assets under management.
Roche Venture Fund last fund was created/launched in 2002-12-17
Yes, Roche Venture Fund is impact investor.
Roche Venture Fund can be reached through its website roche.com/careers, its LinkedIn page and its X account. Its general enquiries address is cv@roche.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Roche Venture Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Roche Venture Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 11 May, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.